oral cancer | GenomeWeb

oral cancer

By analyzing mutations in tumors from a broad swath of tobacco smoke-related cancer types, investigators identified more than two-dozen mutational signatures.

This Week in PNAS

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

The firm's PCR-based products for HPV-associated cancers look at DNA methylation at specific genes and include several sample preparation kits.

The kit targets several mRNA biomarkers and is the first in a series of salivary diagnostic kits the firm plans to develop for early-stage disease diagnostics.

Researchers saw high recurrence risk in oropharyngeal carcinoma patients with human papillomavirus type 16 DNA in their spit samples both before and after treatment.

Researchers hope to advance the technology to support an assay to help personalize oral cancer treatment by avoiding the development of mucositis.

NEW YORK (GenomeWeb) – Canadian molecular diagnostics company Proteocyte Diagnostics today said that it closed a funding round that raised C$605,000 (US$554,000).

NEW YORK (GenomeWeb News) – LED Medical Diagnostics this week announced an agreement to form a collaboration to develop and commercialize a progression-risk assessment test for oral cancer.

NEW YORK (GenomeWeb News) – The National Institute of Dental and Craniofacial Research plans to award $1.5 million next year to fund researchers delving into the molecular and cell-level biology of cancer initiating cells (CICs), also called cancer stem cells, which may be involved in oral cancer

NEW YORK (GenomeWeb News) – Scientists at The University of California, San Francisco and New York University will use a National Cancer Institute grant to fund a study to validate biomarkers that could be used to make important treatment decisions for oral cancer patients.

Pages

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.